aibio
Debt Financing ·
Odyssey Health extends two note maturities to January 2027
Two notes held by LGH Investments, LLC and Peter J. D'Arruda now mature on January 31, 2027. All other terms stay the same, the filing says.
ODYY Odyssey Health, Inc.
Odyssey Health (ODYY) news
Latest Odyssey Health news
We have not published a story on Odyssey Health yet. When there is news, it will appear here.
What Odyssey Health does
Odyssey Health, Inc. is a Nevada corporation based in Las Vegas. Its mission is to create or acquire distinct assets, intellectual property and technologies with superior clinical utility that serve an unmet medical need. Its business model is to develop or acquire medical products, engage third parties to help develop them, complete clinical trials and manufacture products according to FDA regulations. It has two technologies. The CardioMap heart monitoring and screening device uses a novel method of Dispersion Mapping in electrocardiogram analysis for early, non-invasive testing for coronary heart disease. The Save-A-Life choking rescue device uses an internal pump to create a vacuum that dislodges a lodged mass from a choking victim's throat. The company is not selling or marketing any products and has no products authorized for commercial distribution in the United States, Europe or any other country. Due to funding constraints, Save-A-Life will be prioritized and the CardioMap development program will remain suspended in the near term. Its stock is listed on the OTCID Marketplace.
| Product or program | What it is | Stage |
|---|---|---|
| CardioMap | Heart monitoring and screening device for coronary heart disease | development program suspended in the near term; FDA clearance not obtained |
| Save-A-Life | Choking rescue device using a vacuum pump | in development; FDA clearance not obtained |
Odyssey Health annual financials
| Line | FY ended Jul 31, 2026 | FY ended Jul 31, 2025 |
|---|---|---|
| Research and development | $0 | $22,625 |
| Net income (loss) | -$5.7 million | -$1.7 million |
| Cash from operations | -$1.0 million | -$347,392 |
| Cash and equivalents | $122,361 | $19,084 |
Questions about Odyssey Health
What is the ticker symbol of Odyssey Health?
Odyssey Health, Inc. trades under the ticker ODYY on OTC.
Where is Odyssey Health listed?
Odyssey Health, Inc. is listed on OTC.
Which country or territory is Odyssey Health listed under?
Our directory records Odyssey Health, Inc. under United States.
Does aibio.space cover Odyssey Health?
aibio.space lists Odyssey Health, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
What does Odyssey Health develop?
Odyssey Health, Inc. is a Nevada corporation based in Las Vegas. Its mission is to create or acquire distinct assets, intellectual property and technologies with superior clinical utility that serve an unmet medical need.
What is CardioMap from Odyssey Health?
CardioMap: Heart monitoring and screening device for coronary heart disease Stage: development program suspended in the near term; FDA clearance not obtained.
What is Save-A-Life from Odyssey Health?
Save-A-Life: Choking rescue device using a vacuum pump Stage: in development; FDA clearance not obtained.
Is Odyssey Health profitable?
Odyssey Health, Inc. reported a net loss of $5.7 million for the fiscal year ended Jul 31, 2026, and used $1.0 million of cash in operations, per its annual report to the SEC.
How much does Odyssey Health spend on research and development?
$0 in the fiscal year ended Jul 31, 2026, per its annual report.
How much cash does Odyssey Health have?
$122,361 in cash at Jul 31, 2026, per its 10-K.
What is the latest Odyssey Health (ODYY) stock news?
Our latest story on Odyssey Health, dated Sep 29, 2026: "Odyssey Health extends two note maturities to January 2027". Two notes held by LGH Investments, LLC and Peter J. D'Arruda now mature on January 31, 2027. All other terms stay the same, the filing says. Source.
Does Odyssey Health have debt, a term loan or convertible notes?
Our latest debt story, dated Sep 29, 2026: "Odyssey Health extends two note maturities to January 2027". Two notes held by LGH Investments, LLC and Peter J. D'Arruda now mature on January 31, 2027. All other terms stay the same, the filing says. Source.
How can I follow Odyssey Health (ODYY) news?
Press Follow on this page to add Odyssey Health to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Odyssey Health so far, in Debt Financing.
Investor discussion: Odyssey Health
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- Odyssey Health, Inc.
- Ticker
- ODYY
- Listing
- OTC
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction